General Information of Drug Off-Target (DOT) (ID: OTXOSGIB)

DOT Name NKG2-F type II integral membrane protein (KLRC4)
Synonyms NK cell receptor F; NKG2-F-activating NK receptor
Gene Name KLRC4
Related Disease
Behcet disease ( )
Small lymphocytic lymphoma ( )
Chronic hepatitis B virus infection ( )
UniProt ID
NKG2F_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MNKQRGTYSEVSLAQDPKRQQRKLKGNKISISGTKQEIFQVELNLQNASSDHQGNDKTYH
CKGLLPPPEKLTAEVLGIICIVLMATVLKTIVLIPCIGVLEQNNFSLNRRMQKARHCGHC
PEEWITYSNSCYYIGKERRTWEERVCWPVLRRTLICFL
Function May play a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells.
Tissue Specificity Natural killer cells.
KEGG Pathway
Antigen processing and presentation (hsa04612 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Behcet disease DISSYMBS Strong Genetic Variation [1]
Small lymphocytic lymphoma DIS30POX Strong Biomarker [2]
Chronic hepatitis B virus infection DISHL4NT moderate Genetic Variation [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of NKG2-F type II integral membrane protein (KLRC4). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol affects the expression of NKG2-F type II integral membrane protein (KLRC4). [5]
------------------------------------------------------------------------------------

References

1 Genetic polymorphisms of C-type lectin receptors in Behcet's disease in a Chinese Han population.Sci Rep. 2017 Jul 13;7(1):5348. doi: 10.1038/s41598-017-05877-x.
2 Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.Blood. 2008 Feb 1;111(3):1625-33. doi: 10.1182/blood-2007-08-110130. Epub 2007 Nov 15.
3 Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population.J Med Virol. 2010 Sep;82(9):1501-7. doi: 10.1002/jmv.21855.
4 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
5 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.